Clinical trials: Chronic Bacterial Prostatitis
Chronic Bacterial Prostatitis
Prulifloxacin in Chronic Bacterial Prostatitis (CBP)
The aim of the study is to assess the efficacy and safety of prulifloxacin in comparison to levofloxacin in the treatment of patients affected by CBP.
- Trial name
- NCT03201796
- Testing
- Prulifloxacin 600 mg, Levofloxacin 500mg
- Where
- 11 sites in Greece, Italy
- Volunteers
- 168 people
- Sponsor
- Aziende Chimiche Riunite Angelini Francesco S.p.A
Prostatitis
A Study to Evaluate the Safety and Effectiveness of Levofloxacin Compared With Ciprofloxacin in Patients With Chronic Bacterial Prostatitis
The purpose of this study is to compare the safety and effectiveness of levofloxacin to ciprofloxacin in patients with chronic bacterial prostatitis.
- Trial name
- NCT00236808
- Testing
- levofloxacin
- Volunteers
- 383 people
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Prostatitis
Levofloxacin, Chronic Bacterial Prostatitis
Primary objective: To investigate the microbiological efficacy, assessed as eradication rate based on microbiologically evaluable patients 1 month post treatment with oral Levofloxacin 500 mg in male adults with chronic bacterial…
- Trial name
- NCT00277511
- Testing
- Levofloxacin
- Where
- Germany
- Volunteers
- 120 people
- Sponsor
- Sanofi
Prostatitis
An Effectiveness and Safety Study of ELMIRON (Pentosan Polysulfate Sodium) for the Treatment of Chronic Non-Bacterial Inflammation of the Prostate Gland
The purpose of this study is to evaluate the safety and effectiveness of ELMIRON® in the treatment of chronic non-bacterial inflammation of the prostate gland.
- Trial name
- NCT00236990
- Testing
- pentosan polysulfate sodium
- Volunteers
- 283 people
- Sponsor
- McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.